Annovis Bio (ANVS)

• Market cap: $104M
• 1 day: 3.97%
• 5 days: -11.69%
• 1 month: 29.7%
• 3 months: 65.82%
• 6 months: 38.87%
• Year to date: -23.09%
• 1 year: -21.4%
• 5 years: -33.95%
• 10 years: -59.02%
• Sector: Healthcare
• Industry: Biotechnology

About: Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.

Employees: 6